Click here to download and read the full FRN Research Brief.
The illicit use of opioids has reached epidemic proportions in the United States (Alford, 2007; Meges et al, 2014). Americans consume a greatly disproportionate amount of opioids: While Americans constituted 4.6% of the world’s population, they consumed 80% of the global opioid supply in 2007 (Manchikanti et al, 2010). Heroin use is on the rise again with last year use by persons aged 12 and older peaking in 2012 at nearly 6.7 million (SAMHSA, 2012). Additionally, the CDC reports that prescription painkiller sales to pharmacies, hospitals, and doctors’ offices was four times greater in 2010 than in 1999 (National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention, 2012) and average sales of opioids per person in the US increased by 402% between 1997 and 2007 (Manchikanti, Fellows, Allinani and Pampati, 2010). This epidemic of opiate abuse in the United States not only dramatically affects patient lives but also impacts use of health care services.
Foundations Recovery Network (FRN) is an integrated treatment provider committed to offering evidence-based care that produces enduring sobriety rates. Patients who are treated at FRN’s facilities are statistically more than twice as likely to stay sober than the national average and are less likely to be hospitalized or be readmitted for treatment.
FRN facilities offer Dual Diagnosis Enhanced care that includes integrated treatment for substance use disorders and mental health disorders. Patients receive care based on individualized treatment plans that meet medical, psychological and social needs. Scientific research and government entities, including the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), support evidence that treating patients for both mental health and addiction in a coordinated, integrated plan produces better long-term outcomes (SAMHSA, 2011).
Foundations Recovery Network Treatment Outcomes
Opiate Use and Patient Demographics
It is important to note that opiate use may be shifting, making it more crucial to offer effective interventions for this population. While the number of people who used OxyContin non-medically declined from 566,000 in 2010 to 358,000 in 2012, reports show heroin use may be on the rise. Heroin use was steady in 2012 but was higher than a decade earlier. Prescription opiate addicts may be switching to heroin as a more affordable option (SAMHSA, 2013a).
In the meantime, hospitalizations for opiates are still highest for prescription drugs. Oxycodone-based medications were the pain relievers most commonly involved in emergency room visits (56.2 visits per 100,000). After oxycodone—hydrocodone, methadone and morphine products followed with 31.2, 24.3 and 12.3 visits per 100,000, respectively (SAMHSA, 2013b).
Effective treatment for patients’ addiction to opiates is more important than ever before. Beyond the serious health consequences of abusing opiates, there are other related issues. Premature death from HIV and hepatitis is a risk, even after people stop opiate use (Butler, 2010). Furthermore, nonmedical use of prescription painkillers increases violence and some types of crime (Catalonoa et al., 2011).
Meeting the Needs of Opiate-Addicted Patients
Patients who present to treatment at FRN have specific needs related to employment and type of addiction. Since patients are more likely to be employed, they benefit from a treatment continuum that is sensitive to their employment situation and follows them from residential treatment into outpatient treatment. The recognition of unique patient needs helps FRN offer treatments that reduce hospital stays at one-year as well as reduce substance abuse rates and mental health symptoms (MacMaster, Bride, Morse, et al, 2014).
FRN Research Model
Data is collected using validated instruments, including the Addiction Severity Index, Treatment Service Review and University of Rhode Island Change Assessment (URICA – Readiness for Change Instrument). Responses from the research instruments are designed to assess several aspects of a patient’s mental and physical functioning and all other aspects affecting a patient’s life, including alcohol use, drug use, psychiatric symptoms, legal issues, family/social relationships, medical issues and employment issues.
Outcomes for Opiate Users at FRN Facilities
The follow-up study had a 77.9% participation rate. At six months post-treatment, these patients were asked to report their days of opiate use per month, as they had at intake. Our findings reflect that between intake and six months post-treatment, heroin use decreased by 85.16%, non-medical methadone decreased by 97.2% and the use of other opiates decreased by 84.53% (MacMaster, Bride, Morse, et al, 2014).
Results also indicated that 73.2% of opiate users were abstinent of alcohol after six months, and 80.5% were abstinent of drugs. The number of days worked improved even though there was no statistically significant change in employment (MacMaster, Bride, Morse, et al, 2014).
Finally, the study revealed that there was more than an 83% average decrease in the use of any substance overall, and there was a 91% decrease in overall opiate use. Participants reported that they worked more days on average post-treatment, and the amount of illegal income obtained and spending on drugs decreased significantly (MacMaster, Bride, Morse, et al, 2014).
Foundations Recovery Network is committed to research that improves treatment for all addicted individuals. If you would like to speak with an admissions coordinator today or if you would like to learn more about our research methods and programs, please visit us online at https://www.foundationsrecoverynetwork.com or call us directly at 877-714-1318.
Butler, S. B. (2010). Characteristics of prescription opioid abusers in treatment: prescription opioid history, age, use patterns and functional severity. Journal of Opioid Management, 239-41, 246-52.
Catalonoa, R.F., White, H.R., Fleming, C.B. and Haggerty, K.P. (2011). “Is nonmedical prescription opiate use a unique form of illicit drug use?” Addictive Behaviors, 36(1-2): 79-86.
Humphreys, K., & Frank, R. G. (2014). The Affordable Care Act will revolutionize care for substance use disorders in the United States. Addiction, doi: 10.1111/add.12606.
MacMaster SA, Bride BE, Morse SA, Watson C, and Choi, S. (2014). A Comparison of Opioid and non-Opioid Substance Users in Residential Treatment for Co-Occurring Substance Use and Mental Disorders. Under review at Journal of Addictive Behaviors, Therapy & Rehabilitation.
Owens, P. L., Barrett, M. L., Weiss, A. J., Washington, R. E., & Kronick, R. (2014). Hospital inpatient utilization related to opioid overuse among adults, 1993-2012. Healthcare Cost and Utilization Project. Rockville: Agency for Healthcare Research and Quality.
Shanahan, C. W., Beers, D., Alford, D. P., Brigandi, E., & Samet, J. H. (2010). A transitional opioid program to engage hospitalized drug users. Journal of General Internal Medicine, 25 (8), 803-808.
Substance Abuse and Mental Health Services Administration. (2011). Dual Diagnosis Capability in Addiction Treatment Toolkit Version 4.0. Rockville, MD: SAMHSA.
SAMHSA. (2013). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH. Rockville, MD: SAMHSA.
SAMHSA. (2013b). The Drug Abuse Warning Network (DAWN) Report. Retrieved September 8, 2014, from SAMHSA: http://www.samhsa.gov/data/2k13/DAWN127/sr127-DAWN-highlights.pdf
White, W. L. (2012). Recovery/remission from substance use disorders: An analysis of reported outcomes in 415 scientific reports, 1868-2011. Substance Abuse and Mental Health Services Administration. Philadelphia: Philadelphia Department of Behavioral Health and Intellectual disAbility Services and the Great Lakes Addiction Technology Transfer Center.